Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Zappalà

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Tumori|May 9, 2002
[Chronotherapy]C Garufi, A M Aschelter, A R Zappalà, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II studyC Garufi, C Nisticò, S Brienza, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 26, 2021
Clinical Predictors of Response to Anti-PD-1 First-Line Treatment in a Single-Centre Patient Cohort: A Real-World StudyF R Di Pietro, S Verkhovskaia, S Mastroeni, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Tumori|May 9, 2002
[Chronotherapy]C Garufi, A M Aschelter, A R Zappalà, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II studyC Garufi, C Nisticò, S Brienza, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 26, 2021
Clinical Predictors of Response to Anti-PD-1 First-Line Treatment in a Single-Centre Patient Cohort: A Real-World StudyF R Di Pietro, S Verkhovskaia, S Mastroeni, et al.
Pageof 1